Target intelligence / Profile preview

Fibrin knob-hole interaction sites

Molecular classification
Protein-protein interaction site, Structural protein component
01

Overview

Fibrin knob-hole interaction sites are the fundamental structural interfaces that drive the polymerization of fibrinogen into a fibrin mesh during blood coagulation (Weisel JW, 2005, Adv Protein Chem). This process begins when thrombin cleaves fibrinopeptides A and B from the central E-region of fibrinogen, exposing N-terminal 'knobs' known as A-knobs and B-knobs. These knobs specifically dock into complementary 'holes' (a-holes and b-holes) located in the C-terminal D-regions of adjacent fibrin molecules (Spraggon G, et al., 1997, Nature). The A-a interaction is primarily responsible for the longitudinal assembly of protofibrils, while the B-b interaction contributes to lateral aggregation and fiber thickening (Litvinov RI, et al., 2005, Blood). Because these interactions are essential for the formation and stability of a thrombus, they represent a significant therapeutic target for the development of next-generation anticoagulants. Small molecule or peptide mimetics, such as Gly-Pro-Arg-Pro (GPRP), bind to these holes to competitively inhibit fibrin assembly. This approach offers a mechanism to prevent or dissolve pathological clots without necessarily affecting the enzymatic activity of thrombin or other coagulation factors.

Other names
Fibrin polymerization sitesA-a and B-b interactionsKnob-hole junctionsFibrinogen D-domain holesFibrinogen E-domain knobsFibrin self-assembly sites
02

Mechanism of action

Competitive inhibition of fibrin monomer polymerization by binding to the 'hole' pockets in the D-nodule, preventing the 'knob' sequences in the E-nodule from docking (Litvinov RI, et al., 2005, Blood).

03

Biological functions

Blood coagulationFibrin polymerizationHemostasisWound healingThrombus stabilization
04

Disease associations

ThrombosisCardiovascular diseaseStrokePulmonary embolismDisseminated intravascular coagulation
05

Safety considerations

Risk of hemorrhageInhibition of physiological hemostasisPotential for impaired wound healingShort half-life of peptide-based inhibitors
06

Interacting drugs

GPRP (Gly-Pro-Arg-Pro)

4 more in the full profile.

07

Biomarkers

D-dimerFibrinogen levelsThrombin timeProthrombin time

Beyond the preview

Go deeper on Fibrin knob-hole interaction sites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibrin knob-hole interaction sites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call